
Opinion|Videos|January 2, 2025
Need for Sustained Delivery of Anti-VEGF in Retinal Diseases
Panelists discuss how the chronic nature of retinal diseases requires consistent VEGF suppression through regular anti-VEGF injections, but this treatment burden leads to challenges including patient compliance, health care resource strain, and quality of life impacts from frequent office visits.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
- Why is sustained delivery of anti-VEGF necessary, and what challenges arise from frequent anti-VEGF injections?
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy
2
8 things to know about aflibercept 8 mg for retinal vascular disease
3
The Retina TL;DR with Dr. Weng: Targeting the Fas signaling pathway with David Zacks, MD, PhD
4
First patient treated in dose-expansion portion of SpliceBio's phase 1/2 ASTRA clinical trial
5











































